Search research articles
Contact Us
Filters
Showing results (1-10 of 206) with videos related to
Page
of 21
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
January 8, 2013
[Strategic formulation study on dry powder inhalation system based on modulated molecular properties and controlled pharmacokinetics]
Satomi Onoue
Biological & Pharmaceutical Bulletin
|
November 4, 2024
New Drug Delivery Systems for Stable Oral Absorption: Theory, Strategies, and Applications
Satomi Onoue
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
June 3, 2021
[Establishment and International Harmonization of Photosafety Testing Strategy]
Satomi Onoue
Pharmaceutical Research
|
November 26, 2005
Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances
Satomi Onoue, Yoshiko Tsuda
Peptides
|
June 1, 2007
Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD
Satomi Onoue, Shizuo Yamada, Takehiko Yajima
Journal of Applied Toxicology : JAT
|
January 29, 2013
Development of an albuminous reactive oxygen species assay for photosafety evaluation under experimental biomimetic conditions
Satomi Onoue, Masashi Kato, Shizuo Yamada
Pharmaceutical Research
|
March 13, 2024
Importance of Considering Fed-State Gastrointestinal Physiology in Predicting the Reabsorption of Enterohepatic Circulation of Drugs
Kohei Nakamura, Atsushi Kambayashi, Satomi Onoue
The FEBS Journal
|
October 31, 2008
Pituitary adenylate cyclase-activating polypeptide attenuates streptozotocin-induced apoptotic death of RIN-m5F cells through regulation of Bcl-2 family protein mRNA expression
Satomi Onoue, Junko Hanato, Shizuo Yamada
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 4, 2008
Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications
Satomi Onoue, Shingen Misaka, Shizuo Yamada
Biopharmaceutics & Drug Disposition
|
January 5, 2021
Biopharmaceutical characterization of a novel sustained-release formulation of allopurinol with reduced nephrotoxicity
Takuya Nihei, Hideyuki Sato, Satomi Onoue
Page
of 21
Search research articles
Search
Showing results (1-10 of 206) with videos related to
Sort By:
Page
of 21
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
January 8, 2013
[Strategic formulation study on dry powder inhalation system based on modulated molecular properties and controlled pharmacokinetics]
Satomi Onoue
Biological & Pharmaceutical Bulletin
|
November 4, 2024
New Drug Delivery Systems for Stable Oral Absorption: Theory, Strategies, and Applications
Satomi Onoue
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
June 3, 2021
[Establishment and International Harmonization of Photosafety Testing Strategy]
Satomi Onoue
Pharmaceutical Research
|
November 26, 2005
Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances
Satomi Onoue, Yoshiko Tsuda
Peptides
|
June 1, 2007
Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD
Satomi Onoue, Shizuo Yamada, Takehiko Yajima
Journal of Applied Toxicology : JAT
|
January 29, 2013
Development of an albuminous reactive oxygen species assay for photosafety evaluation under experimental biomimetic conditions
Satomi Onoue, Masashi Kato, Shizuo Yamada
Pharmaceutical Research
|
March 13, 2024
Importance of Considering Fed-State Gastrointestinal Physiology in Predicting the Reabsorption of Enterohepatic Circulation of Drugs
Kohei Nakamura, Atsushi Kambayashi, Satomi Onoue
The FEBS Journal
|
October 31, 2008
Pituitary adenylate cyclase-activating polypeptide attenuates streptozotocin-induced apoptotic death of RIN-m5F cells through regulation of Bcl-2 family protein mRNA expression
Satomi Onoue, Junko Hanato, Shizuo Yamada
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 4, 2008
Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications
Satomi Onoue, Shingen Misaka, Shizuo Yamada
Biopharmaceutics & Drug Disposition
|
January 5, 2021
Biopharmaceutical characterization of a novel sustained-release formulation of allopurinol with reduced nephrotoxicity
Takuya Nihei, Hideyuki Sato, Satomi Onoue
Page
of 21